{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T17:17:29Z","timestamp":1783099049137,"version":"3.54.6"},"reference-count":44,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:00:00Z","timestamp":1768867200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.xcrm.2026.102630","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T15:47:06Z","timestamp":1771429626000},"page":"102630","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["HIF-activated priming of TRAIL-induced cell death determines epigenetic vulnerability in kidney cancer"],"prefix":"10.1016","volume":"7","author":[{"given":"Yong","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuiqiao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilia","family":"Korboukh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyang","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanina","family":"Toffessi Tcheuyap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sipeng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Brugarolas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingfei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1992-0320","authenticated-orcid":false,"given":"Weibo","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2026.102630_bib1","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/s41581-020-0301-x","article-title":"Genomic profiling in renal cell carcinoma","volume":"16","author":"Dizman","year":"2020","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.xcrm.2026.102630_bib2","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1126\/science.1059817","article-title":"HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing","volume":"292","author":"Ivan","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2026.102630_bib3","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0092-8674(01)00507-4","article-title":"C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation","volume":"107","author":"Epstein","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.102630_bib4","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/20459","article-title":"The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis","volume":"399","author":"Maxwell","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.102630_bib5","doi-asserted-by":"crossref","first-page":"5510","DOI":"10.1073\/pnas.92.12.5510","article-title":"Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension","volume":"92","author":"Wang","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2026.102630_bib6","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1101\/gad.11.1.72","article-title":"Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells","volume":"11","author":"Tian","year":"1997","journal-title":"Genes Dev."},{"key":"10.1016\/j.xcrm.2026.102630_bib7","first-page":"205","article-title":"Molecular characterization and chromosomal localization of a third alpha-class hypoxia inducible factor subunit, HIF3alpha","volume":"7","author":"Gu","year":"1998","journal-title":"Gene Expr."},{"key":"10.1016\/j.xcrm.2026.102630_bib8","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.molcel.2008.04.009","article-title":"Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway","volume":"30","author":"Kaelin","year":"2008","journal-title":"Mol. Cell"},{"key":"10.1016\/j.xcrm.2026.102630_bib9","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.molcel.2010.09.022","article-title":"Hypoxia-inducible factors and the response to hypoxic stress","volume":"40","author":"Majmundar","year":"2010","journal-title":"Mol. Cell"},{"key":"10.1016\/j.xcrm.2026.102630_bib10","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1158\/1078-0432.CCR-19-1459","article-title":"HIF-2 complex dissociation, target inhibition, and acquired resistance with PT2385, a first-in-class HIF-2 inhibitor, in patients with clear cell renal cell carcinoma","volume":"26","author":"Courtney","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2026.102630_bib11","doi-asserted-by":"crossref","first-page":"S1329","DOI":"10.1016\/j.annonc.2023.10.090","article-title":"Belzutifan versus everolimus in participants (pts) with previously treated advanced clear cell renal cell carcinoma (ccRCC): Randomized open-label phase III LITESPARK-005 study","volume":"34","author":"Albiges","year":"2023","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.xcrm.2026.102630_bib12","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1101\/gad.1256804","article-title":"Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1\/TSC2 tumor suppressor complex","volume":"18","author":"Brugarolas","year":"2004","journal-title":"Genes Dev."},{"key":"10.1016\/j.xcrm.2026.102630_bib13","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1158\/2159-8290.CD-11-0098","article-title":"Genetic and functional studies implicate HIF1alpha as a 14q kidney cancer suppressor gene","volume":"1","author":"Shen","year":"2011","journal-title":"Cancer Discov."},{"key":"10.1016\/j.xcrm.2026.102630_bib14","article-title":"Treatment strategies for clear cell renal cell carcinoma: Past, present and future","volume":"13","author":"Yang","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.xcrm.2026.102630_bib15","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.trecan.2023.02.001","article-title":"Cell death, therapeutics, and the immune response in cancer","volume":"9","author":"Hanggi","year":"2023","journal-title":"Trends Cancer"},{"key":"10.1016\/j.xcrm.2026.102630_bib16","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1172\/JCI6926","article-title":"Safety and antitumor activity of recombinant soluble Apo2 ligand","volume":"104","author":"Ashkenazi","year":"1999","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.xcrm.2026.102630_bib17","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.7150\/ijms.51703","article-title":"Characteristics and prognostic value of potential dependency genes in clear cell renal cell carcinoma based on a large-scale CRISPR-Cas9 and RNAi screening database DepMap","volume":"18","author":"Shi","year":"2021","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.xcrm.2026.102630_bib18","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a041053","article-title":"The death receptor pathway of apoptosis","volume":"14","author":"Green","year":"2022","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.xcrm.2026.102630_bib19","doi-asserted-by":"crossref","first-page":"13884","DOI":"10.1073\/pnas.241358198","article-title":"Caspase-10 is an initiator caspase in death receptor signaling","volume":"98","author":"Wang","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2026.102630_bib20","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/s41571-020-0341-y","article-title":"Targeting apoptosis in cancer therapy","volume":"17","author":"Carneiro","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.xcrm.2026.102630_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.628332","article-title":"The TRAIL in the treatment of human cancer: an update on clinical trials","volume":"8","author":"Snajdauf","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.xcrm.2026.102630_bib22","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aay0482","article-title":"HIF-independent synthetic lethality between CDK4\/6 inhibition and VHL loss across species","volume":"12","author":"Nicholson","year":"2019","journal-title":"Sci. Signal."},{"key":"10.1016\/j.xcrm.2026.102630_bib23","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202404693","article-title":"Methuosis Inducer SGI-1027 Cooperates with Everolimus to Promote Apoptosis and Pyroptosis by Triggering Lysosomal Membrane Permeability in Renal Cancer","volume":"11","author":"Luo","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.xcrm.2026.102630_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-030-12734-3_1","article-title":"Hypoxia mediates tumor malignancy and therapy resistance","volume":"1136","author":"Luo","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.xcrm.2026.102630_bib25","doi-asserted-by":"crossref","first-page":"6293","DOI":"10.1074\/jbc.M114.594671","article-title":"New insights on the mechanism of quinoline-based DNA Methyltransferase inhibitors","volume":"290","author":"Gros","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.xcrm.2026.102630_bib26","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1016\/j.bmc.2013.03.033","article-title":"Structure-activity relationships for 4-anilinoquinoline derivatives as inhibitors of the DNA methyltransferase enzyme DNMT1","volume":"21","author":"Gamage","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.xcrm.2026.102630_bib27","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/cmdc.201300420","article-title":"Design, synthesis and biological evaluation of 4-amino-N- (4-aminophenyl)benzamide analogues of quinoline-based SGI-1027 as inhibitors of DNA methylation","volume":"9","author":"Rilova","year":"2014","journal-title":"ChemMedChem"},{"key":"10.1016\/j.xcrm.2026.102630_bib28","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13148-019-0663-8","article-title":"Identification of a novel quinoline-based DNA demethylating compound highly potent in cancer cells","volume":"11","author":"Zwergel","year":"2019","journal-title":"Clin. Epigenetics"},{"key":"10.1016\/j.xcrm.2026.102630_bib29","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13526","article-title":"Inhibition of DNA methyltransferase aberrations reinstates antioxidant aging suppressors and ameliorates renal aging","volume":"21","author":"Gao","year":"2022","journal-title":"Aging Cell"},{"key":"10.1016\/j.xcrm.2026.102630_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.110055","article-title":"A renal cell carcinoma tumorgraft platform to advance precision medicine","volume":"37","author":"Elias","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.xcrm.2026.102630_bib31","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s10637-017-0536-y","article-title":"Phase III study of dulanermin (recombinant human tumor necrosis factor-related apoptosis-inducing ligand\/Apo2 ligand) combined with vinorelbine and cisplatin in patients with advanced non-small-cell lung cancer","volume":"36","author":"Ouyang","year":"2018","journal-title":"Invest. New Drugs"},{"key":"10.1016\/j.xcrm.2026.102630_bib32","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nature12222","article-title":"Comprehensive molecular characterization of clear cell renal cell carcinoma","volume":"499","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.102630_bib33","article-title":"PBRM1 deficiency sensitizes renal cancer cells to DNMT inhibitor 5-Fluoro-2'-Deoxycytidine","volume":"12","author":"Gu","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.xcrm.2026.102630_bib34","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1002\/1878-0261.13040","article-title":"Genome-wide analysis of DNA methylation identifies the apoptosis-related gene UQCRH as a tumor suppressor in renal cancer","volume":"16","author":"Miyakuni","year":"2022","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.xcrm.2026.102630_bib35","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1248\/cpb.30.1018","article-title":"Mode of action of 5-fluorocytidine and 5-fluoro-2'-deoxycytidine in L5178Y cells in vitro","volume":"30","author":"Yoshida","year":"1982","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.xcrm.2026.102630_bib36","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1128\/MCB.01799-07","article-title":"DNA methylation inhibitor 5-Aza-2'-deoxycytidine induces reversible genome-wide DNA damage that is distinctly influenced by DNA methyltransferases 1 and 3B","volume":"28","author":"Palii","year":"2008","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.xcrm.2026.102630_bib37","doi-asserted-by":"crossref","first-page":"5483","DOI":"10.1038\/sj.onc.1205699","article-title":"5-Azacytidine and 5-aza-2'-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy","volume":"21","author":"Christman","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.xcrm.2026.102630_bib38","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nature19796","article-title":"Targeting renal cell carcinoma with a HIF-2 antagonist","volume":"539","author":"Chen","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.102630_bib39","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1056\/NEJMoa0806277","article-title":"PHD2 mutation and congenital erythrocytosis with paraganglioma","volume":"359","author":"Ladroue","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2026.102630_bib40","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1093\/hmg\/ddi227","article-title":"Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations","volume":"14","author":"Pollard","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.xcrm.2026.102630_bib41","doi-asserted-by":"crossref","first-page":"6198","DOI":"10.3390\/ijms23116198","article-title":"No time to die: how kidney cancer evades cell death","volume":"23","author":"Ganini","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.xcrm.2026.102630_bib42","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1172\/JCI95089","article-title":"ZMYND8 acetylation mediates HIF-dependent breast cancer progression and metastasis","volume":"128","author":"Chen","year":"2018","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.xcrm.2026.102630_bib43","doi-asserted-by":"crossref","DOI":"10.1172\/JCI168362","article-title":"SAP30 promotes breast tumor progression by bridging the transcriptional corepressor SIN3 complex and MLL1","volume":"133","author":"Bao","year":"2023","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.xcrm.2026.102630_bib44","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1091\/mbc.e14-02-0775","article-title":"PHD3-mediated prolyl hydroxylation of nonmuscle actin impairs polymerization and cell motility","volume":"25","author":"Luo","year":"2014","journal-title":"Mol. Biol. Cell"}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379126000479?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379126000479?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T16:23:46Z","timestamp":1783095826000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379126000479"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S2666379126000479"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.102630","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HIF-activated priming of TRAIL-induced cell death determines epigenetic vulnerability in kidney cancer","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.102630","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102630"}}